CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration

September 3, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), a leader in the development and sale of high-quality CBD and wellness products, is pleased to announce that President Donald Trump has confirmed his administration is actively considering the rescheduling of marijuana under the Controlled Substances Act. This announcement, highlighted in a recent JD Supra legal analysis, signals what may be the most pivotal regulatory moment in the history of the cannabis...

Read more

Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio

September 3, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced a new distribution partnership in the United Kingdom with Pioneer Veterinary Products Limited, one of the region's most respected veterinary distributors. The agreement begins with the distribution of Zomedica's TRUFORMA® diagnostic platform throughout...

Read more

Ascelia Pharma Submits Orviglance New Drug Application to the U.S. Food and Drug Administration

September 3, 2025 4:30 AM

Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that the New Drug Application (NDA) for Orviglance® has been submitted to the US Food and Drug Administration (FDA).The NDA for Orviglance has been submitted to the FDA. Ascelia Pharma seeks marketing approval for Orviglance as liver MRI contrast agent for patients with severe kidney impairment. The...

Read more

Releaf Acquires Domain Releaf.com for £110,000

September 2, 2025 12:00 PM

Releaf, the UK's fastest-growing medicinal cannabis clinic, has acquired the domain Releaf.com for £110,000 as part of its global expansion strategy. The move comes as the company overtakes £2.1 million in monthly revenue and prepares to take its proven healthcare model to international markets.Releaf's technology platform, fully integrated with the NHS Spine, now serves over 300,000 unique website visitors monthly. The platform uses AI-assisted...

Read more

Releaf Acquires Domain Releaf.com for £110,000

September 2, 2025 12:00 PM

Releaf, the UK's fastest-growing medicinal cannabis clinic, has acquired the domain Releaf.com for £110,000 as part of its global expansion strategy. The move comes as the company overtakes £2.1 million in monthly revenue and prepares to take its proven healthcare model to international markets.Releaf's technology platform, fully integrated with the NHS Spine, now serves over 300,000 unique website visitors monthly. The platform uses AI-assisted...

Read more

Florence Announces AI-Assisted Workflows to Transform Clinical Trials

September 2, 2025 11:00 AM

Ahead of its premier life science event advancing Clinical Trial technology and innovation, Research Revolution, Florence Healthcare today announced its upcoming AI-centric workflows aimed at transforming clinical trials conducted across the study life-cycle. These solutions will significantly accelerate and enhance site identification, feasibility, start up, study conduct and remote monitoring for both sites and sponsors.Built in collaboration...

Read more

Fenja Capital II A/S Requests Conversion of All Outstanding Convertibles for a Total Nominal Amount of SEK 7.5 Million

September 2, 2025 10:25 AM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB ("Ascelia Pharma" or the "Company") issued on 13 September 2024, convertibles to Fenja Capital II A/S ("Fenja Capital") with an aggregate nominal amount of SEK 7.5 million. Fenja Capital has now requested conversion of all outstanding convertibles whereby a total of 2,218,933 new ordinary shares are issued to Fenja Capital at a conversion price of SEK 3.38 per share.As a result of the conversion of...

Read more

Emergency Physician Gianluca Cerri Featured for Insightful Career and Innovation in Medicine

September 2, 2025 9:45 AM

Gianluca Cerri, MD, an accomplished emergency medicine physician known for blending practical solutions with forward-thinking ideas, is the focus of a newly released career spotlight article. The piece explores how Dr. Cerri's decades of experience in both high-volume trauma centres and resource-limited rural hospitals have shaped his approach to problem-solving, innovation, and patient care.The feature traces Dr. Cerri's professional journey...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Patent-Pending AI Mental Health Tracker Targeting $400 Billion Market

September 2, 2025 9:35 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), an innovator in AI-powered healthcare technologies, today announced its AI Mental Health Tracker, a breakthrough solution designed to transform how anxiety, depression, and PTSD are detected and monitored. Visit the official site for more details at https://medicalcaretechnologies.com.The. patent pending proprietary platform will leverage high-frame-rate facial landmark tracking, temporal...

Read more

VSee Health Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue

September 2, 2025 9:00 AM

VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, today announced the expansion implementation of 17/of 25 teleradiology. VSee health was awarded an increase to 22 hospitals by a significant vendor who recently awarded an additional 3 hospitals. VSee Health has now implemented 17 of those hospitals by end of August this year. The contract value with this expansion is almost 3 million per year in ARR.The initial pilot of 3...

Read more

New World Medical Introduces the Ahmed ClearPath(R) ST Glaucoma Drainage Device

September 2, 2025 9:00 AM

New World Medical, a leading innovator in ophthalmic surgical devices, proudly announces the launch of the Ahmed ClearPath® ST, a non-valved glaucoma drainage device. Building on the success of the Ahmed ClearPath®, the new model introduces key differences designed to provide surgeons more options to fit their patient's needs. A distinguishing feature of the Ahmed ClearPath® STis its smaller tube lumen, that also includes a pre-threaded 6-0...

Read more

MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions

September 2, 2025 9:00 AM

MicroGenDX, a national pioneer in molecular diagnostics, has incorporated Illumina's MiSeq i100 plus sequencing platform to reshape the future of infectious disease testing. Since the MiSeq's rollout in July, MicroGenDX has been delivering its leading-edge Next-Generation DNA Sequencing (NGS) testing within 24 hours of sample receipt.By shrinking the diagnostic delay, the time between test and treatment, healthcare providers gain insights that...

Read more

CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors

September 2, 2025 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced the appointment of Barbara Krebs-Pohl, PhD as an Independent Director to the CASI Board of Directors.Dr. Krebs-Pohl is a highly respected leader in the biotechnology sector with over 27 years of experience, particularly in development,...

Read more

1933 Industries Announces Repurchase and Cancellation of Convertible Debentures

September 2, 2025 8:30 AM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that it has entered into a Debenture Repurchase Agreement (the "Agreements") with two arm's length parties (together the "Vendors"), for the repurchase and cancellation of a portion of Company's outstanding unsecured convertible debentures.Pursuant to the Agreements, the Company will...

Read more

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism

September 2, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2025 International Congress of Inborn Errors of Metabolism (ICIEM), which will be held September 2-6, 2025 in Kyoto, Japan, at the Kyoto International Conference Center. This includes three oral presentations and two poster presentations across the Company's propionic acidemia (PA), methylmalonic...

Read more

Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt

September 2, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT) is pleased to announce the receipt of the Semaglutide active pharmaceutical ingredient (API), enabling the initiation of laboratory-scale formulation and testing of the Company's oral dissolvable film (ODF) delivery system.In collaboration with its qualified supply partners, BioNxt has secured high-purity Semaglutide as the central compound for its proprietary...

Read more

Gubra Announces Completion of Solar & Battery Park

September 2, 2025 1:50 AM

Gubra (CPH:GUBRA) - Gubra announces the upcoming launch of a 2MW solar and battery park in Sorø, Denmark. The park, completed and currently awaiting grid connection, is the latest initiative under Gubra Green, our subsidiary that allocates 10% of Gubra's annual pre-tax profit to projects advancing a net-zero, nature-positive future.Powering Gubra with Renewable ElectricityElectricity accounts for around 75% of Gubra's operational greenhouse gas...

Read more

Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes

September 1, 2025 10:35 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised £620,000 through the issue of convertible loan notes (the "CLNs"). As the Company continues the clinical trial of HG-CT-1, its CAR-T cell therapy for relapsed or refractory acute myeloid leukemia, it was approached by a small investor group offering to provide funding to support the ongoing clinical trial.Convertible Loan NotesTo support the clinical trial, the...

Read more

Pharma Contract Manufacturing is the Quiet Reshoring Engine Investors Can’t Ignore

September 1, 2025 7:30 AM

The hottest new healthcare investment target for Q4 2025 isn't a flashy digital health app or AI scribe. According to a Black Book Research flash survey last week of 78 venture capital, private equity, investment banking, and healthcare technology influencer respondents, it's pharmaceutical contract manufacturing organizations (CMOs) and supply chain resilience.62% of respondents ranked CMOs as their top healthcare investment sector for expected...

Read more

Bausch Health Launches YUN Probiotherapy(TM) ACN Skincare Line in Poland

September 1, 2025 1:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the launch of the YUN ACN skincare line in Poland, offering probiotic and prebiotic formulations designed for acne-prone skin. Following Bausch Health's partnership announcement with YUN NV last June, YUN Probiotherapy™ ACN products are now available in pharmacies across Poland. The skincare product range includes YUN ACN Repair Cream,...

Read more